Effects of selective alpha 2-adrenoreceptor stimulation on capsaicin-evoked substance P release from primary cultured dorsal root ganglion neurons.

Huicui Gong,Qian Liu,Xiangdong Yang,Zhen Liu,Guixiang Liu,Zhenzhong Li
DOI: https://doi.org/10.1691/ph.2010.9697
2010-01-01
Pharmazie
Abstract:Alpha(2) adrenoreceptors are expressed in dorsal root ganglion (DRG) neurons and may be involved in inflammation or other physiological and pathophysiological conditions To determine the effects of administration of selective alpha(2) adrenoreceptor agonists or antagonists on substance P (SP) release from DRG neurons without or with capsaicin stimulation, primary cultured embryonic rat DRG neurons were preincubated with the selective alpha(2) adrenoreceptor agonist clonidine (10(-5) mol/L) or the alpha(2) adrenoreceptor antagonist yohimbine (10(-5) mol/L) for 4 days, respectively, followed by the addition of capsaicin (10(-7) nmol/L) for additional 10 min Cultures were examined by radioimmunoassay (RIA) for detecting SP levels released from DRG neurons before and after capsaicin stimulation Expression of SP mRNA and vanilloid receptor 1 (VR1) mRNA was determined by RT-PCR Administration of the selective alpha(2) adrenoreceptor agonist clonidine for 4 days could decrease capsaicin-evoked SP release but not basal SP release Administration of clonidine could decrease VR1 mRNA expression but not SP mRNA. Administration of the selective alpha(2) adrenoreceptor antagonist yohimbine did not have these effects The inhibitory role of the selective alpha(2) adrenoreceptor agonist clonidine on capsaicin-evoked SP release may be through decreasing VR1 mRNA levels then reducing the sensitivity of nociceptors to capsaicin. The data provided in the present study suggest that adrenergic modulation on primary sensory neurons by an alpha(2) adrenoreceptor agonist may contribute to the analgesic effects in neurogenic inflammation.
What problem does this paper attempt to address?